Corbus Pharmaceuticals (CRBP) Live Share Price, Invest From India

Corbus Pharmaceuticals Stock Performance

as on October 23, 2026 at 6:59 am IST

Day's Low
Day's High
$4.03
Day's Price Range
$4.52
$4.14
2.66%
Downside
9.18%
Upside
52 Week's Low
52 Week's High
$4.22
52-Week Price Range
$19.55
$4.14
-1.93%
Downside
372.22%
Upside

Corbus Pharmaceuticals share price movements today

Previous Close: $4.29
Open: $4.39
Volume: 1.2M
Market Cap: $85.5M
Day's Low - High: $4.03 - $4.52
52 Week Low - High: $4.22 - $19.55

Corbus Pharmaceuticals Historical Returns

1 Month Return: -45.59 %
3 Month Return: -51.53 %
1 Year Return: -75.85 %
3 Year Return: -28.58 %
5 Year Return: -84.98 %

Corbus Pharmaceuticals Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$85.5M

EPS (TTM)

-6.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.68

Industry PE ratio

-3.16

PEG Ratio

0.02

EBITDA

-101.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-87.05%

Corbus Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Corbus Pharmaceuticals	StrongBuy	$85.5M	-84.98%	-0.68	0.00%	0.00%
Moderna	Neutral	$96.6B	-24.72%	-30.34	-12.57%	0.00%
BeOne Medicines	StrongBuy	$43.7B	NA	26.25	87.82%	0.00%
Vertex Pharmaceuticals	StrongBuy	$130.4B	185.81%	29.71	86.04%	0.00%
Regeneron	Buy	$83.1B	40.76%	19.28	84.86%	0.46%

Stock Returns calculator for Corbus Pharmaceuticals Stock including INR - Dollar returns

The Corbus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Corbus Pharmaceuticals investment value today

Current value as on today

₹25,220

Returns

-₹74,780

(-74.78%)

Returns from Corbus Pharmaceuticals Stock

-₹76,663 (-76.66%)

Dollar Impact

₹1,882 (+1.88%)

Analyst Recommendation on Corbus Pharmaceuticals Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals. Average target price of $34.02

Corbus Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals.

What analysts predicted

87.83%UPSIDE

Target Price

$34.02

Current Price

$4.14

Analyzed by

7 Analysts

High

$48

Target

$34.02

Low

$30

Corbus Pharmaceuticals target price $34.02, a slight upside of 87.83% compared to current price of $4.14. According to 7 analysts rating.

Indian Investors' Interest in Corbus Pharmaceuticals Stock

Search interest for Corbus Pharmaceuticals Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 23, 2026 to October 23, 2026

Change:-55% versus previous 30 day period

Corbus Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	0	-	0	-15	0	-	-	0	-
Operating Income	-9	-10	-15	-12	-19	-19	-24	-21	-24	-36
EBITDA	-5	-9	-13	-9	-18	-17	-23	-20	-22	-34
Interest Expense	0	0	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-9	-13	-9	-16	-17	-23	-20	-22	-35
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-6	-9	-13	-9	-16	-17	-23	-20	-22	-35
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	2	4	36	3	0	-	-	-	-
Gross Profit	-23	-43	-53	3	0	-1	-	0	-
Operating Income	-32	-56	-77	-122	-55	-34	-45	-48	-85
EBITDA	-32	-56	-75	-121	-42	-38	-40	-37	-78
Interest Expense	-	-	-	1	1	2	2	1	-
Depreciation	0	0	1	1	1	1	0	0	0
Income Before Tax	-32	-55	-71	-111	-45	-42	-44	-40	-78
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-32	-55	-71	-111	-45	-55	-44	-40	-78
Net Profit Margin	-967.09%	-908.11%	-147.91%	100.00%	-85.92%	0.00%	0.00%	0.00%	0.00%

Corbus Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-6	-9	-13	-9	-16	-17	-23	-20	-22	-35
Operating Cash Flow	-7	-8	-13	-10	-16	-16	-15	-15	-25	-29
Investing Cash Flow	-98	-16	-15	8	18	17	19	-57	22	18
Financing Cash Flow	106	34	25	0	-	-	2	74	-	9
Change in Cash	0	9	-4	-2	1	1	6	1	-3	-2

Corbus Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-32	-55	-71	-111	-45	-42	-44,603	-40	-78
Operating Cash Flow	-27	-30	-45	-99	-48	-37	-36,100	-41	-64
Investing Cash Flow	0	-2	-2	0	-73	30	35,641	-121	-1
Financing Cash Flow	76	11	38	154	60	0	-2,820	166	77
Change in Cash	47	-20	-9	54	-60	-8	-3,279	3	11

Global Institutional Holdings in Corbus Pharmaceuticals

Check out the Institutions with significant holdings in Corbus Pharmaceuticals.

Funds	Holdings
Vanguard	4.39%
VANGUARD INDEX FUNDS	3.68%
iShares	3.30%
Fidelity Concord Street Trust	0.79%
Global X	0.79%

See all

Insights on Corbus Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 815.5% return, outperforming this stock by 891.3%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 205.7% return, outperforming this stock by 234.3%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CRBP stock has moved down by -45.6%

About Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.

Organisation	Corbus Pharmaceuticals
Headquarters	500 River Ridge Drive, Norwood, MA, 02062, US
Industry	Biotechnology
CEO	Yuval Cohen

Key Management of Corbus Pharmaceuticals

Name	Title
Mr. Sean F. Moran CPA, M.B.A.	Chief Financial Officer
Dr. Ian Hodgson B.Sc., Ph.D.	Chief Operating Officer
Mr. G. Scott Goeken J.D., M.S.	General Counsel & Corporate Secretary
Ms. Christina Bertsch M.A.	Vice President of Human Resources
Mr. Nishant C. Saxena	Chief Business Officer
Dr. Leonardo Viana Nicacio M.D.	Chief Medical Officer
Dr. Yuval Cohen Ph.D.	CEO & Director

FAQs

What is Corbus Pharmaceuticals share price today?

Corbus Pharmaceuticals share price today is $4.14 as on October 23, 2026 at 1:29 am IST at the close of the market. Corbus Pharmaceuticals share today touched a day high of $4.52 and a low of $4.03.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals share?

Corbus Pharmaceuticals share touched a 52 week high of $19.55 on October 22, 2025 and a 52 week low of $4.22 on October 16, 2026. Corbus Pharmaceuticals stock price today i.e. October 23, 2026 at 1:29 am IST is closed at $4.14,which is 78.82% down from its 52 week high and -1.90% up from its 52 week low.

What is Corbus Pharmaceuticals's market capitalisation today?

Corbus Pharmaceuticals market capitalisation is $0.00T as on October 23, 2026 at 1:29 am IST.

How to invest in Corbus Pharmaceuticals Stock (CRBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Corbus Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Corbus Pharmaceuticals Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals (CRBP) shares with as little as ₹94.81749725341797 or $1 (as of October 23, 2026 at 4:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Corbus Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on October 23, 2026 at 4:42 am IST). Based on Corbus Pharmaceuticals share’s latest price of $4.14 as on October 23, 2026 at 1:29 am IST, you will get 2.4155 shares of Corbus Pharmaceuticals. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals stock has given -84.98% share price returns and 26.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?